This page is part of the US Quality Core (v0.5.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Profile: US Quality Core MedicationRequest
status: Active
intent: Order
medication: Medication alemtuzumab 10 MG/ML [Lemtrada]
authoredOn: 2015-03-25 19:32:52-0500
requester: Practitioner Adam Careful
reasonCode: Multiple sclerosis requiring disease-modifying therapy
reasonReference: Multiple sclerosis requiring disease-modifying therapy
dosageInstruction
text: Infuse alemtuzumab 12 mg intravenously once daily for 5 days.
timing: 1-1 per 1-1 day
asNeeded: false
route: Infusion, intravenous
DoseAndRates
Type Dose[x] Ordered 12 mg (Details: UCUM codemg = 'mg')
dispenseRequest
validityPeriod: 2015-03-25 --> 2015-04-01
numberOfRepeatsAllowed: 0
quantity: 6 mL (Details: UCUM codemL = 'mL')
ExpectedSupplyDurations
Value Unit System Code 5 days http://unitsofmeasure.org d